- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06170502
Developing and Evaluating a Mobil Application AKILMOBIL
Developing and Evaluating a Mobil Application for Rational Drug Use in Parents of Pediatric Patients After Discharge (Akilmobil)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The irrational use of drugs is a major problem all over the world. About half of the patients cannot use the drugs correctly. Over, under or misuse of drugs leads to waste of resources and poor health conditions. The patients and their relatives who manage the use of drugs at home are most important componenets in this regard. Administration of the medication at home to the children mostly lead by parents.
Despite being informed during discharge, parents can make many mistakes in adjusting the dosage, preparing and administering tablet, capsule, suspension forms of drugs. And there are difficulties in accessing reliable sources of information.
It is necessary to keep the knowledge and skills of the parents of children with chronic diseases, who uses drugs for a long time, up-to-date. Therefore, continuous and accessible training and support systems are needed. Recently, mobile applications that can be easily accessed from mobile phones have become widespread thanks to technological developments. Regardless of their socioeconomic level, anyone with a smartphone can use these applications. A mobile application with home drug preparation and application can provide information and support for parents in the preparation and administration of appropriate doses.
For this reason, the aim of this project is to develop and evaluate a mobile application (AkilMobil) that prevents parents who continue to use drugs for their children at home after their child is discharged from the hospital. The research is a randomized controlled experimental study. In the study, "Education Needs of Parents who Administering Medicines at Home Form", "Descriptive Information Form", "Parental Drug Preparation Information Evaluation Form", " Suspension Drug Administration Parent Evaluation Form", "Capsule Drug Administration Parent Evaluation Form", "Tablet Drug Administration Parent Evaluation Form", "Mobile Application Usability Questionnaire", "AkilMobil Expert Opinion Evaluation Form" developed by the researchers in line with the literature, and "STAI State Anxiety Inventory" developed by Spielberger et al. will be used.
In the application, there will be drug information, indications, effects, side effects, preparation and administration methods, instructions for use, drug interaction information, dose calculation and drug preparation videos of drugs that are frequently used in chronic diseases, which are understood by parents. Interaction with users will be provided with frequently asked questions and the opportunity to ask researchers directly. With this application, parents can prevent dose errors due to lack of information while preparing drugs at home and information pollution due to applying to incorrect and insufficient sources. The mobile application's ease of access, presentation of visual resources and providing understandable information are the original values of our work. It is a technological advance for rational drug use and quality health care.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ayşegül Karaca
- Phone Number: 05337691532
- Email: aysegulkara_88@hotmail.com
Study Locations
-
-
Mamak
-
Ankara, Mamak, Turkey, 06100
- Recruiting
- Aysegul
-
Contact:
- ayşegül karaca
- Phone Number: 05337691532
- Email: aysegulkaraca_88@hotmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Treating the disease condition and being discharged
- Continuing to use medication at home after discharge
- Parents should be able to speak and understand Turkish and be literate.
- Having an Android mobile phone for the mobile application
- Having the video call application on the mobile phone and accepting the video calling application to be made after 1 month
- Voluntary written and verbal informed consent has been obtained from the parents.
Exclusion Criteria:
- Parents' unwillingness to continue working at any stage of the research
- Termination of drug use due to the termination of their children's treatment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: mobile application development and implementation
The aim of the project is to develop and evaluate the effectiveness of a mobile application (AkilMobil) that prevents parents who continue to use drugs for their children at home after their child is discharged from the hospital.
The research is a randomized controlled experimental study.
In the study, "The Form for Determining the Educational Needs of Parents Administering Medicines at Home", "Introductory Information Form", "Parental Drug Preparation Information Evaluation Form", "Parent Evaluation Form in Suspension Drug Administration", "Capsule Drug Application Parent Evaluation Form", developed by the researchers in line with the literature, "Tablet Pharmaceutical Application Parent Evaluation Form", "Mobile Application Usability Questionnaire", "AkilMobil Expert Opinion Evaluation Form" and "STAI State Anxiety Inventory" developed by Spielberger et al. will be used.
|
In the study, "The Form for Determining the Educational Needs of Parents Administering Medicines at Home", "Introductory Information Form", "Parental Drug Preparation Information Evaluation Form", "Parent Evaluation Form in Suspension Drug Administration", "Capsule Drug Application Parent Evaluation Form", developed by the researchers in line with the literature, "Tablet Pharmaceutical Application Parent Evaluation Form", "Mobile Application Usability Questionnaire", "AkilMobil Expert Opinion Evaluation Form" and "STAI State Anxiety Inventory" developed by Spielberger et al. will be used.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mobile Application Usability Survey
Time Frame: 3 months
|
Mothers with children with chronic diseases were evaluated with a mobile application usability survey, change in medication preparation activities in the 3rd month.
|
3 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- TUBITAK 2023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Survey Application
-
Boston Children's HospitalDayton Children's Hospital; GetWellNetworkTerminatedInpatient Experience Survey Administration | Inpatient Experience Survey ResponseUnited States
-
Laval UniversityCompleted
-
Our Lady of Lourdes Hospital, DroghedaUnknown
-
University Hospital, Basel, SwitzerlandCompleted
-
Universitair Ziekenhuis BrusselCompleted
-
Moens MaartenVrije Universiteit BrusselRecruitingSurvey | Neuromodulation | RegistryGermany
-
University of Alabama at BirminghamWithdrawn
-
Universitair Ziekenhuis BrusselCompleted
-
Aretaieion University HospitalCompleted
-
Tanta UniversityCompleted
Clinical Trials on Using the mobile application and applying the survey
-
National Taiwan University Hospital Hsin-Chu BranchNational Taipei University of Nursing and Health SciencesRecruitingWound | Pressure InjuryTaiwan
-
Karolinska InstitutetThe Swedish Research CouncilCompletedBurnout, Professional | Stress, PsychologicalSweden
-
CochlearRecruiting
-
Hospital Universitari de BellvitgeNot yet recruitingQuality of Life | Asthma | Telemedicine | Adherence, Treatment | Control
-
Duke UniversityGenzyme, a Sanofi CompanyRecruitingLate-Onset Pompe Disease | Lysosomal DiseaseUnited States
-
Assiut UniversityNot yet recruitingAdherence, Medication | Bronchial Asthma
-
Assistance Publique - Hôpitaux de ParisWithdrawn
-
University of OklahomaRecruiting
-
Riphah International UniversityCompleted
-
Istanbul University - Cerrahpasa (IUC)CompletedMultisensory StimulationTurkey